Lexaria Bioscience Corp. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lexaria Bioscience Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
  • Lexaria Bioscience Corp. Share-based Payment Arrangement, Expense for the quarter ending November 30, 2024 was $99.4K, a 84.3% increase year-over-year.
  • Lexaria Bioscience Corp. annual Share-based Payment Arrangement, Expense for 2023 was $170K, a 77.4% decline from 2022.
  • Lexaria Bioscience Corp. annual Share-based Payment Arrangement, Expense for 2022 was $753K, a 83.6% increase from 2021.
  • Lexaria Bioscience Corp. annual Share-based Payment Arrangement, Expense for 2021 was $410K, a 64% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $170K -$582K -77.4% Sep 1, 2022 Aug 31, 2023 10-K 2023-11-20
2022 $753K +$343K +83.6% Sep 1, 2021 Aug 31, 2022 10-K 2023-11-20
2021 $410K -$729K -64% Sep 1, 2020 Aug 31, 2021 10-K 2022-11-28
2020 $1.14M +$513K +81.8% Sep 1, 2019 Aug 31, 2020 10-K 2021-11-29
2019 $627K -$1.98M -75.9% Sep 1, 2018 Aug 31, 2019 10-K 2020-10-15
2018 $2.6M +$2.49M +2202% Sep 1, 2017 Aug 31, 2018 10-K 2019-11-14
2017 $113K -$8.97K -7.35% Sep 1, 2016 Aug 31, 2017 10-K 2018-11-14
2016 $122K Sep 1, 2015 Aug 31, 2016 10-K 2018-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.